openPR Logo
Press release

CD Bioparticles Launches Endotoxin Free Gold Nanoparticles for Biomedical Research and Bioassay Development

10-28-2024 06:32 PM CET | Health & Medicine

Press release from: ABNewswire

CD Bioparticles Launches Endotoxin Free Gold Nanoparticles

CD Bioparticles announces its new Endotoxin Free Gold Nanoparticles for biomedical research and bioassay development.
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces the availability of its new Endotoxin Free Gold Nanoparticles [https://www.cd-bioparticles.com/product/endotoxin-free-gold-nanoparticles-356.html] for biomedical research and bioassay development. These nanoparticles offer exceptional biocompatibility and can meet the stringent requirements of researchers and developers working in a variety of fields, including drug delivery, imaging, sensing, medical diagnostics, and therapeutics.

Endotoxin-free gold nanoparticles are specially engineered gold particles with extremely low levels of endotoxin, a toxic substance produced by certain types of bacteria, the presence of which can interfere with experimental results or damage cells or tissues. These nanoparticles are typically coated with citrate to minimize their interaction with biological systems and increase their biocompatibility. Endotoxin-free gold nanoparticles are widely used in biomedical research and bioassay development.

Committed to providing innovative and high-performance biomaterials, CD Bioparticles offers endotoxin-free gold nanoparticles for research applications requiring minimal levels of contamination, such as cytotoxicity studies, immunological studies and sterility testing. The endotoxin content of all batches has been verified by Limulus amebocyte lysate (LAL) testing. These nanoparticles offer exceptional purity and minimal endotoxin contamination to ensure reliable and reproducible results and are suitable for applications such as drug delivery, imaging, and biosensing.

Endotoxin-free gold nanoparticles from CD Bioparticles are available in a range of sizes from 5 nm to 400 nm. These particles exhibit strong light scattering and absorption in the visible and near-infrared regions, making them ideal for various applications. Their renewable nature, excellent thermal, mechanical, and chemical stability, and low toxicity ensure their versatility and safety. Moreover, the surface chemistry of these nanoparticles can be easily modified with biomolecules like antibodies, aptamers, or peptides, enabling precise targeting of specific cells, tissues, or biomolecules.

CD Bioparticles offers a range of functional group/ligand endotoxin free gold nanoparticles to meet diverse research and diagnostic needs, including citric acid-stabilized endotoxin free gold nanoparticles and tannic acid-stabilized endotoxin free gold nanoparticles. For example, the DiagNano Trademark Gold Nanoparticles, Endotoxin Free, 100 nm (Cat. No.BG-100-EF) are citric acid-stabilized gold nanoparticles, with a maximum absorbance of 572 nm, supplied in 0.1 mM phosphate-buffered saline. These nanoparticles boast a purity of over 99.0% and are free of extraneous reactants. With endotoxin levels below 0.5 EU/mL, they are ideal for cellular studies and exhibit exceptional protein binding efficiency. To ensure optimal sterility, the nanoparticles are packaged in dust-free containers, maintaining the highest level of cleanliness.

CD Bioparticles is dedicated to supporting researchers and scientists with their material needs by providing innovative products and exceptional services. These biocompatible nanoparticles offer researchers a powerful tool for advancing their work in a variety of fields. For more information about Endotoxin Free Gold Nanoparticles and other products, please visit https://www.cd-bioparticles.com/product/endotoxin-free-gold-nanoparticles-356.html.

About CD Bioparticles

CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.

Media Contact
Company Name: CD Bioparticles
Contact Person: Richard J. Gray
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-bioparticles-launches-endotoxin-free-gold-nanoparticles-for-biomedical-research-and-bioassay-development]
State: New York
Country: United States
Website: https://www.cd-bioparticles.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CD Bioparticles Launches Endotoxin Free Gold Nanoparticles for Biomedical Research and Bioassay Development here

News-ID: 3712780 • Views:

More Releases from ABNewswire

Ecosense Expands U.S. Market with BestBuy.com Launch
Ecosense Expands U.S. Market with BestBuy.com Launch
Radon Detection Leader Now Makes Complete Line of Smart Digital Radon Monitors Available to American Consumers San Jose, CA - August 28, 2025 - Ecosense [https://ecosense.io/], the global leader in radon detection and monitoring solutions, is pleased to announce that its award-winning residential radon monitors can now be purchased on BestBuy.com in the United States. Following its launch with Best Buy Canada the year before last, this announcement is the second
Graft vs Host Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Cellestia Biotech, Pfizer, Chia Tai Tianqing Pharma, Regimmune Corp
Graft vs Host Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clini …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Graft vs Host Disease pipeline constitutes 45+ key companies continuously working towards developing 50+ Graft vs Host Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Graft vs Host Disease Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/graft-versus-host-disease-gvhd-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Graft
Hearthfire Holdings Increases Chicago Metro Footprint with Crest Hill Self-Storage Development Purchase
Hearthfire Holdings Increases Chicago Metro Footprint with Crest Hill Self-Stora …
Philadelphia-Based Investment Company Acquires Fourth Chicago-Area Property, Forms Joint Venture with Condev Land and Development Group PHILADELPHIA, PA - August 28th, 2025 - Hearthfire Holdings [https://hfirecapital.com/], a real estate investment company focused on self-storage assets, today announced another closed Joint Venture with the purchase of a shovel-ready development site in Crest Hill, Illinois, its fourth project in the Chicago metro market. The purchase kicks off a joint venture partnership with Condev Land
Chronic Hepatitis B Virus Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Ascletis Pharma, Shanghai HEP Pharma, Romark Lab, Qilu Pharma
Chronic Hepatitis B Virus Pipeline 2025: MOA and ROA Insights, Clinical Trials S …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Hepatitis B Virus pipeline constitutes 50+ key companies continuously working towards developing 55+ Chronic Hepatitis B Virus treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Chronic Hepatitis B Virus Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/chronic-hepatitis-b-virus-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Chronic

All 5 Releases


More Releases for Bioparticles

CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Parti …
CD Bioparticles announces its advanced line of multiplex fluorescence particles. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles [https://www.cd-bioparticles.com/products/multiplex-assays-466.html] designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter and fluorescence channels. Various surface modifications, channels and sizes are also supported. Flow cytometry is a convenient detection
CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research …
CD Bioparticles proudly announces the launch of its new Functional Agarose Particles. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles proudly announces the launch of its new Functional Agarose Particles [https://www.cd-bioparticles.com/products/functional-agarose-particles-1065.html] designed for a variety of applications in the field of bioconjugation, isolation, and purification of biomacromolecules. These particles are ideal for researchers working in areas such as protein purification, antibody production, and nucleic acid isolation. CD
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Deliv …
CD Bioparticles announces the availability of Polystyrene Family polymers for a variety of drug delivery applications. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce the availability of Polystyrene Family polymers [https://www.cd-bioparticles.net/polystyrene-family] for a variety of drug delivery applications. These polymers offer tunable physicochemical properties that enable sustained release profiles and improved drug bioavailability. The polystyrene family, a group of polymers derived from
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Appl …
CD Bioparticles announces Polyolefin Family polymers for a variety of drug delivery applications. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has recently expanded its low PDI polymer portfolio and announces its new offering of Polyolefin Family [https://www.cd-bioparticles.net/polyolefin-family] polymers with a wide range of properties that make them well-suited for a variety of drug delivery applications. Low dispersion index polymers are polymeric compounds with low molecular
CD Bioparticles Introduces the Launch of Organic Gold Nanoparticles
With years of experience in the pharmaceutical and life science sector, CD Bioparticles now launches a comprehensive list of organic gold nanoparticles for research applications. These organic gold nanoparticles have a hydrophobic surface character and have great solubility in a wide range of organic solvents. CD Bioparticles offers a comprehensive list of coatings, functional and conjugated gold nanoparticles through precise surface engineering. It offers gold nanoparticles functionalized with reactive groups such
CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles recently introduces a series of dendrimers for research use, such as DMPA-G1-TMP-Acetylene, DMPA-G1-TMP-Azide, DMPA-G1-TMP-Carboxyl, and DMPA-G1-TMP-NHBOC. These biodegradable polymers can be used in theranostics, biosensors, optics, adhesives and coatings. With customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms, CD Bioparticles can help scientists to solve problems in the